Financial Reports

Mon, 22 May 2017

Annual report 2016

The Board of Directors and the CEO hereby submit the annual report and consolidated financial statements for Bluefish Pharmaceuticals AB for the 2016 financial year.


For more information, contact


Berit Lindholm, CEO Bluefish Pharmaceuticals 

Tel. 46 8 519 116 00



About Bluefish Pharmaceuticals
Bluefish has undergone significant international expansion since the company was founded in 2005. Bluefish focuses on the development, manufacture and sale of generic pharmaceuticals. The company conducts marketing operations in a large number of European markets and is expanding into territories outside Europe. The product portfolio consists of a total of approximately 80 products and is growing.

Download the annual report as pdf